Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells
We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an...
Gespeichert in:
Veröffentlicht in: | International immunology 1991-08, Vol.3 (8), p.761-767 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 767 |
---|---|
container_issue | 8 |
container_start_page | 761 |
container_title | International immunology |
container_volume | 3 |
creator | Kannagi, Mari Harada, Shinji Maruyama, Ikuro Inoko, Hidetoshi Igarashi, Hisanaga Kuwashima, Gorou Sato, Shigeru Morita, Michio Kidokoro, Minoru Sugimoto, Masanobu Funahashi, Shin-ichi Osame, Mitsuhiro Shida, Hisatoshi |
description | We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders. |
doi_str_mv | 10.1093/intimm/3.8.761 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72107903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72107903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-bc4ac5db1531533999eb1146c99eedc3e9d89aaf480e52c8f04ad849f68071253</originalsourceid><addsrcrecordid>eNpFUU2LFDEQDaKs4-rVm5CTKNKzSac_kuMyq9sDI64wyuIlpJPqMe50MiZp2fkz_laz9qBQUEW9V6-Kegi9pGRJiWAX1iU7jhdsyZdtQx-hBa0aUpSsbR-jBRE1Kzht-VP0LMYfhBBWCnaGzqigtK7qBfp9E8D40TrlEg6g_c7ZZL3DfsDfp1E5vMUa9nu8h-kORqvwLxumiNPxAHiN33Tbzddi_RYfbvEOHOBD8GbSKeL-eJpfXfF3WB-TT_7e6pNcxMbmbQkMVjtlXUx4ViqsG-b-X9pz9GRQ-wgvTvkcffnwfrvqis2n6_XqclPosiGp6HWldG16WrMcTAgBPc2P0LkAoxkIw4VSQ8UJ1KXmA6mU4ZUYGk5aWtbsHL2edfP9PyeISY42PlygHPgpyrakpBWEZeJyJurgYwwwyEOwowpHSYl8METOhkgmucyG5IFXJ-WpH8H8p88OZLyYcRsT3P-DVbiTTcvaWna33-THbnXTXYnP8pr9Aflil-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72107903</pqid></control><display><type>article</type><title>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Kannagi, Mari ; Harada, Shinji ; Maruyama, Ikuro ; Inoko, Hidetoshi ; Igarashi, Hisanaga ; Kuwashima, Gorou ; Sato, Shigeru ; Morita, Michio ; Kidokoro, Minoru ; Sugimoto, Masanobu ; Funahashi, Shin-ichi ; Osame, Mitsuhiro ; Shida, Hisatoshi</creator><creatorcontrib>Kannagi, Mari ; Harada, Shinji ; Maruyama, Ikuro ; Inoko, Hidetoshi ; Igarashi, Hisanaga ; Kuwashima, Gorou ; Sato, Shigeru ; Morita, Michio ; Kidokoro, Minoru ; Sugimoto, Masanobu ; Funahashi, Shin-ichi ; Osame, Mitsuhiro ; Shida, Hisatoshi</creatorcontrib><description>We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.</description><identifier>ISSN: 0953-8178</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/3.8.761</identifier><identifier>PMID: 1911545</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; AIDS/HIV ; B-Lymphocytes - immunology ; CD8 Antigens - analysis ; Cell Line ; class I major histocompatibility complex ; Female ; Gene Products, tax - immunology ; HLA-A2 Antigen - immunology ; HTLV-I Infections - immunology ; HTLV-I-associated myelopathy ; Humans ; p40tax ; Paraparesis, Tropical Spastic - immunology ; Phenotype ; recombinant vaccinia virus ; T-Lymphocytes, Cytotoxic - immunology</subject><ispartof>International immunology, 1991-08, Vol.3 (8), p.761-767</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260t-bc4ac5db1531533999eb1146c99eedc3e9d89aaf480e52c8f04ad849f68071253</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1911545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kannagi, Mari</creatorcontrib><creatorcontrib>Harada, Shinji</creatorcontrib><creatorcontrib>Maruyama, Ikuro</creatorcontrib><creatorcontrib>Inoko, Hidetoshi</creatorcontrib><creatorcontrib>Igarashi, Hisanaga</creatorcontrib><creatorcontrib>Kuwashima, Gorou</creatorcontrib><creatorcontrib>Sato, Shigeru</creatorcontrib><creatorcontrib>Morita, Michio</creatorcontrib><creatorcontrib>Kidokoro, Minoru</creatorcontrib><creatorcontrib>Sugimoto, Masanobu</creatorcontrib><creatorcontrib>Funahashi, Shin-ichi</creatorcontrib><creatorcontrib>Osame, Mitsuhiro</creatorcontrib><creatorcontrib>Shida, Hisatoshi</creatorcontrib><title>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</title><title>International immunology</title><addtitle>Int Immunol</addtitle><description>We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>B-Lymphocytes - immunology</subject><subject>CD8 Antigens - analysis</subject><subject>Cell Line</subject><subject>class I major histocompatibility complex</subject><subject>Female</subject><subject>Gene Products, tax - immunology</subject><subject>HLA-A2 Antigen - immunology</subject><subject>HTLV-I Infections - immunology</subject><subject>HTLV-I-associated myelopathy</subject><subject>Humans</subject><subject>p40tax</subject><subject>Paraparesis, Tropical Spastic - immunology</subject><subject>Phenotype</subject><subject>recombinant vaccinia virus</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><issn>0953-8178</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUU2LFDEQDaKs4-rVm5CTKNKzSac_kuMyq9sDI64wyuIlpJPqMe50MiZp2fkz_laz9qBQUEW9V6-Kegi9pGRJiWAX1iU7jhdsyZdtQx-hBa0aUpSsbR-jBRE1Kzht-VP0LMYfhBBWCnaGzqigtK7qBfp9E8D40TrlEg6g_c7ZZL3DfsDfp1E5vMUa9nu8h-kORqvwLxumiNPxAHiN33Tbzddi_RYfbvEOHOBD8GbSKeL-eJpfXfF3WB-TT_7e6pNcxMbmbQkMVjtlXUx4ViqsG-b-X9pz9GRQ-wgvTvkcffnwfrvqis2n6_XqclPosiGp6HWldG16WrMcTAgBPc2P0LkAoxkIw4VSQ8UJ1KXmA6mU4ZUYGk5aWtbsHL2edfP9PyeISY42PlygHPgpyrakpBWEZeJyJurgYwwwyEOwowpHSYl8METOhkgmucyG5IFXJ-WpH8H8p88OZLyYcRsT3P-DVbiTTcvaWna33-THbnXTXYnP8pr9Aflil-o</recordid><startdate>19910801</startdate><enddate>19910801</enddate><creator>Kannagi, Mari</creator><creator>Harada, Shinji</creator><creator>Maruyama, Ikuro</creator><creator>Inoko, Hidetoshi</creator><creator>Igarashi, Hisanaga</creator><creator>Kuwashima, Gorou</creator><creator>Sato, Shigeru</creator><creator>Morita, Michio</creator><creator>Kidokoro, Minoru</creator><creator>Sugimoto, Masanobu</creator><creator>Funahashi, Shin-ichi</creator><creator>Osame, Mitsuhiro</creator><creator>Shida, Hisatoshi</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910801</creationdate><title>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</title><author>Kannagi, Mari ; Harada, Shinji ; Maruyama, Ikuro ; Inoko, Hidetoshi ; Igarashi, Hisanaga ; Kuwashima, Gorou ; Sato, Shigeru ; Morita, Michio ; Kidokoro, Minoru ; Sugimoto, Masanobu ; Funahashi, Shin-ichi ; Osame, Mitsuhiro ; Shida, Hisatoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-bc4ac5db1531533999eb1146c99eedc3e9d89aaf480e52c8f04ad849f68071253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>B-Lymphocytes - immunology</topic><topic>CD8 Antigens - analysis</topic><topic>Cell Line</topic><topic>class I major histocompatibility complex</topic><topic>Female</topic><topic>Gene Products, tax - immunology</topic><topic>HLA-A2 Antigen - immunology</topic><topic>HTLV-I Infections - immunology</topic><topic>HTLV-I-associated myelopathy</topic><topic>Humans</topic><topic>p40tax</topic><topic>Paraparesis, Tropical Spastic - immunology</topic><topic>Phenotype</topic><topic>recombinant vaccinia virus</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kannagi, Mari</creatorcontrib><creatorcontrib>Harada, Shinji</creatorcontrib><creatorcontrib>Maruyama, Ikuro</creatorcontrib><creatorcontrib>Inoko, Hidetoshi</creatorcontrib><creatorcontrib>Igarashi, Hisanaga</creatorcontrib><creatorcontrib>Kuwashima, Gorou</creatorcontrib><creatorcontrib>Sato, Shigeru</creatorcontrib><creatorcontrib>Morita, Michio</creatorcontrib><creatorcontrib>Kidokoro, Minoru</creatorcontrib><creatorcontrib>Sugimoto, Masanobu</creatorcontrib><creatorcontrib>Funahashi, Shin-ichi</creatorcontrib><creatorcontrib>Osame, Mitsuhiro</creatorcontrib><creatorcontrib>Shida, Hisatoshi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kannagi, Mari</au><au>Harada, Shinji</au><au>Maruyama, Ikuro</au><au>Inoko, Hidetoshi</au><au>Igarashi, Hisanaga</au><au>Kuwashima, Gorou</au><au>Sato, Shigeru</au><au>Morita, Michio</au><au>Kidokoro, Minoru</au><au>Sugimoto, Masanobu</au><au>Funahashi, Shin-ichi</au><au>Osame, Mitsuhiro</au><au>Shida, Hisatoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</atitle><jtitle>International immunology</jtitle><addtitle>Int Immunol</addtitle><date>1991-08-01</date><risdate>1991</risdate><volume>3</volume><issue>8</issue><spage>761</spage><epage>767</epage><pages>761-767</pages><issn>0953-8178</issn><eissn>1460-2377</eissn><abstract>We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>1911545</pmid><doi>10.1093/intimm/3.8.761</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8178 |
ispartof | International immunology, 1991-08, Vol.3 (8), p.761-767 |
issn | 0953-8178 1460-2377 |
language | eng |
recordid | cdi_proquest_miscellaneous_72107903 |
source | MEDLINE; Oxford University Press Journals Digital Archive Legacy |
subjects | Adult AIDS/HIV B-Lymphocytes - immunology CD8 Antigens - analysis Cell Line class I major histocompatibility complex Female Gene Products, tax - immunology HLA-A2 Antigen - immunology HTLV-I Infections - immunology HTLV-I-associated myelopathy Humans p40tax Paraparesis, Tropical Spastic - immunology Phenotype recombinant vaccinia virus T-Lymphocytes, Cytotoxic - immunology |
title | Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T06%3A11%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predominant%20recognition%20of%20human%20T%20cell%20leukemia%20virus%20type%20I%20(HTLV-I)%20pX%20gene%20products%20by%20human%20CD8+%20cytotoxic%20T%20cells%20directed%20against%20HTLV-I-infected%20cells&rft.jtitle=International%20immunology&rft.au=Kannagi,%20Mari&rft.date=1991-08-01&rft.volume=3&rft.issue=8&rft.spage=761&rft.epage=767&rft.pages=761-767&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/3.8.761&rft_dat=%3Cproquest_cross%3E72107903%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72107903&rft_id=info:pmid/1911545&rfr_iscdi=true |